Cargando…

SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada

BACKGROUND: One- and two-dose mRNA vaccine effectiveness (VE) estimates against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by dosing interval and time since vaccination were assessed among healthcare workers (HCWs) in publicly funded acute and community (nonresidential) h...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Adam, Shiraz, Zou, Macy, Kim, Shinhye, Henry, Bonnie, Krajden, Mel, Skowronski, Danuta M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047244/ https://www.ncbi.nlm.nih.gov/pubmed/35531384 http://dx.doi.org/10.1093/ofid/ofac178

Ejemplares similares

Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada
por: Skowronski, Danuta M, et al.
Publicado: (2022)

Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada
por: Skowronski, Danuta M, et al.
Publicado: (2021)

Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada
por: Skowronski, Danuta M, et al.
Publicado: (2022)

Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada
por: Skowronski, Danuta M., et al.
Publicado: (2022)

Correction to: SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada
Publicado: (2022)

Real-world Effectiveness of Sofosbuvir/Velpatasvir for Treatment of Chronic Hepatitis C in British Columbia, Canada: A Population-Based Cohort Study
por: Wilton, James, et al.
Publicado: (2020)

Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada
por: Tanunliong, Guadalein, et al.
Publicado: (2022)

HCV co-infection in HIV positive population in British Columbia, Canada
por: Buxton, Jane A, et al.
Publicado: (2010)

Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016–2017 and 2017–2018 Epidemics in Canada
por: Skowronski, Danuta M, et al.
Publicado: (2020)

Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada
por: Romanowski, Kamila, et al.
Publicado: (2017)

Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada
por: Skowronski, Danuta M., et al.
Publicado: (2023)

Outpatient antibiotic use in British Columbia, Canada: reviewing major trends since 2000
por: Saatchi, Ariana, et al.
Publicado: (2021)

Community Antibiotic Use at the Population Level During the SARS-CoV-2 Pandemic in British Columbia, Canada
por: Mamun, Abdullah A, et al.
Publicado: (2021)

BNT162b2 Effectiveness Against Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2 in Adolescents Aged 12–17 Years, by Dosing Interval and Duration
por: Ionescu, Iulia G, et al.
Publicado: (2023)

Motor vehicle incidents in postgraduate trainees in British Columbia
por: Cassidy, Louise F, et al.
Publicado: (2021)

Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015–2016 Season in Canada
por: Skowronski, Danuta M, et al.
Publicado: (2017)

Human Illness from Avian Influenza H7N3, British Columbia
por: Tweed, S. Aleina, et al.
Publicado: (2004)

Population SARS-CoV-2 Seroprevalence Using Antenatal Serum Samples in British Columbia, Canada
por: McClymont, Elisabeth, et al.
Publicado: (2021)

The impact of COVID-19 pandemic control measures on HCV treatment initiation in British Columbia, Canada
por: Janjua, Naveed, et al.
Publicado: (2022)

COVID-19 vaccine effectiveness in patients with non–dialysis-dependent chronic kidney diseases: findings from a population-based observational study from British Columbia, Canada
por: Atiquzzaman, Mohammad, et al.
Publicado: (2022)

Physical, Psychological, and Cognitive Profile of Post-COVID Conditions in Healthcare Workers, Quebec, Canada
por: Carazo, Sara, et al.
Publicado: (2022)

Prevalence of Human Immunodeficiency Virus-1 Integrase Strand Transfer Inhibitor Resistance in British Columbia, Canada Between 2009 and 2016: A Longitudinal Analysis
por: Kamelian, Kimia, et al.
Publicado: (2019)

COVID Vaccination Rates in Children and Adults with Sickle Cell Disease in British Columbia, Canada
por: Merkeley, Hayley, et al.
Publicado: (2021)

Genotyping and Whole-Genome Sequencing to Identify Tuberculosis Transmission to Pediatric Patients in British Columbia, Canada, 2005–2014
por: Guthrie, Jennifer L, et al.
Publicado: (2018)

Cervical Intraepithelial Neoplasia Rates in British Columbia Women: A Population-Level Data Linkage Evaluation of the School-Based HPV Immunization Program
por: Racey, C Sarai, et al.
Publicado: (2020)

Exploring vaccination practices of midwives in British Columbia
por: Bettinger, Julie A., et al.
Publicado: (2021)

Genomics of Tenacibaculum Species in British Columbia, Canada
por: Nowlan, Joseph P., et al.
Publicado: (2023)

Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada
por: Binka, Mawuena, et al.
Publicado: (2018)

2705. Serotype Replacement Following Childhood Pneumococcal Conjugate Vaccination Programs in British Columbia, Canada
por: Vadlamudi, Nirma K, et al.
Publicado: (2019)

Intentions of public school teachers in British Columbia, Canada to receive a COVID-19 vaccine
por: Racey, C. Sarai, et al.
Publicado: (2021)

Characterization of vaccine confidence among teachers in British Columbia, Canada: A population-based survey
por: Racey, C. Sarai, et al.
Publicado: (2023)

Priorities among effective clinical preventive services in British Columbia, Canada
por: Krueger, Hans, et al.
Publicado: (2022)

The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)
por: Janjua, Naveed Z., et al.
Publicado: (2016)

Towards targeted screening for acute HIV infections in British Columbia
por: Steinberg, Malcolm, et al.
Publicado: (2011)

Differences in Work Disability Duration for Immigrants and Canadian-Born Workers in British Columbia, Canada
por: Senthanar, Sonja, et al.
Publicado: (2021)

Ethnoveterinary medicines used for ruminants in British Columbia, Canada
por: Lans, Cheryl, et al.
Publicado: (2007)

Breast cancer treatment and ethnicity in British Columbia, Canada
por: Yavari, Parvin, et al.
Publicado: (2010)

Cryptococcus gattii Dispersal Mechanisms, British Columbia, Canada
por: Kidd, Sarah E., et al.
Publicado: (2007)

The cost of firearm violent crime in British Columbia, Canada
por: Rajabali, Fahra, et al.
Publicado: (2023)

Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020
por: Skowronski, Danuta M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p35g90im63co6tpltnbd63c4i2